Kathleen Goin

Chief Operating Officer

Kathleen Goin (Chief Operating Officer) filed 11 Form 4 reports in the trailing twelve months (0 purchases, 11 sales), most often in Palvella Therapeutics, Inc. (PVLA). The largest single filing was $655K of PVLA (4,302 sh across 3 lots, as filed), executed Sep 16.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 11 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$4.9M

shares × price, as filed

Last traded

Sep 16

Filed Sep 18

Median ADV $37.6M across their filed names

Open performance→

Volume by month

Buys $0 Sells $4.9M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 11 filings

Sector per market data · by filing · past 12 months

Most traded names

PVLA

Palvella Therapeutics, Inc. PVLA · 0 buys · 11 sells 11 filings

Recent filings

PVLASALE Palvella Therapeutics, Inc. View filing → $655K
4,302 sh across 3 lots
Exec Sep 16
Filed Sep 18 · 4:05 PM ET PVLASALE Palvella Therapeutics, Inc. View filing → $530K
3,498 sh across 2 lots
Exec Aug 19
Filed Aug 20 · 4:05 PM ET PVLASALE Palvella Therapeutics, Inc. View filing → $565K
3,780 sh across 3 lots
Exec Jul 15
Filed Jul 17 · 4:05 PM ET PVLASALE Palvella Therapeutics, Inc. View filing → $474K
4,277 sh across 2 lots
Exec Jun 17
Filed Jun 22 · 5:30 PM ET PVLASALE Palvella Therapeutics, Inc. View filing → $371K
3,363 sh × $110.35
Exec May 20
Filed May 22 · 5:30 PM ET PVLASALE Palvella Therapeutics, Inc. View filing → $380K
3,002 sh across 2 lots
Exec Apr 15
Filed Apr 17 · 5:30 PM ET PVLASALE Palvella Therapeutics, Inc. View filing → $471K
3,998 sh across 2 lots
Exec Mar 18
Filed Mar 20 · 5:30 PM ET PVLASALE Palvella Therapeutics, Inc. View filing → $342K
4,302 sh across 2 lots
Exec Feb 18
Filed Feb 20 · 5:30 PM ET More filings →